Private Equity
VCs are seeing that AI technology could improve health and could eventually have a high payoff for investments, too
6 min read · 03 August 2016
Diablo Technologies, the Ottawa memory-chip developer, secured $37 million in the close of its Series C financing. The oversubscribed round was backed by three global investors, all of them new to the company. They included Israeli venture firm ICV, which led the Series C’s initial $27 million tranche in January. It was joined in a second $10 million tranche, announced today, by New York's Genesis Capital Advisors and Dubai's GII Tech Ventures. Battery Ventures, BDC Capital, Celtic House Venture Partners and Hasso Plattner Ventures, all longtime backers of Diablo, also invested.
3 min read · 02 August 2016
Tech IPO activity remains muted while the biotech window is open in this tale of two markets. Expect more of the same
6 min read · 01 August 2016
UTIMCO's bets in the vintage 2014 funds from GGV Capital and True Ventures are already paying off
2 min read · 28 July 2016
Felicis founder peers beyond simple revenue traction to examine sales per invested dollar and employee
5 min read · 27 July 2016
Just 33 transactions were completed in Q2, another sign that early-stage cleantech investing remains out of favor
2 min read · 27 July 2016
A summary of recent funds closed worldwide, such as Lonsdale 8VC, 500 Startups, Capricorn Venture Partners and Alchemy Ventures
7 min read · 26 July 2016
A total of 18 VC-backed companies were acquired in June, led by the outsized Stemcentrx deal
1 min read · 25 July 2016
IA Ventures and Foundry still lead UTIMCO portfolio, although Pinto, Cendana and Sante each made huge strides in latest report
2 min read · 21 July 2016
Longtime investor Annie Lamont, who spoke at the GES, chats about her views on investing and exiting within fintech and healthcare services
5 min read · 19 July 2016
